NLSDays 2015: Meet international life science leaders and discuss the sector’s future at the Nordic region’s largest partnering meeting

NLSDays September 9-10 at Stockholm Waterfront is the Nordic region’s premier life science event. The global life science sector is undergoing major structural changes, and as part of a strong established hub, companies in Sweden and the Nordic countries are of great interest when international investors and corporations are looking for new partners.

The entire value chain from basic research to the introduction of new therapies is subject to transformation – not least due to rapid developments in digital health. Life science companies therefore need to find new ways to collaborate and fund their projects. Since the Nordic region offers a modern, competitive environment for academia and research companies alike, the region has become highly attractive for the global life science industry.

  • NLSDays has become the most important meeting place for global investors and corporations that are looking for new collaborations in the Nordic region. The event is on course for record numbers and deals such as the recent one between Alligator Bioscience and Janssen Biotech which illustrates that Swedish companies offer major value to partners, says Jonas Ekstrand, CEO SwedenBIO, the Swedish national life science industry organization which founded the event three years ago.

Overall, the life science sector is currently very active in the Nordic countries. For example, the Oslo Cancer Cluster Innovation Park, an investment of around 100 million Euros opens today (24 August). Furthermore, AstraZeneca recently announced a Euros 260 million investment in a new plant for bio-pharmaceutical production and from January 2014, 18 life science companies across all subsectors from medtech to biopharma have been listed on Nasdaq Nordic at a combined value of about Euros 250 million (Source Nasdaq). Furthermore, initiatives and companies in new areas such as personalized medicine, digital health and outcomes based provision are emerging at an accelerating pace.

During Nordic Life Science Days 2015 the main theme is “The New Value Chain”. The 2 day program covers several sessions in which international life science leaders will discuss strategies on how new partnerships can be established and how medical research and the life science industry in the Nordics can contribute.

Super Sessions from the program:

  • International Investors (9 September at 11.30 – 12.30)

International life science investors talk about their investment models and what they look for from entrepreneurs.

  • Personalized Healthcare – Matching Medicines to Patients (September 10 at 08:45 – 09-45)

How will big data and new diagnostic methods impact the future of medical research and treatment modalities? Listen to how the Digital Doctor Watson can revolutionize health care.

  • Oncology 2025 (10 September 11.30 – 12.30)

Immuno-oncology is hotter than ever and there is an ongoing competition between the big global companies to take on the most promising projects. Representatives from several of the major players talk about their strategies.

Currently, 800 delegates are registered for this year’s NLSDays, which is 33% more than at the corresponding time last year. This strongly indicate that the meeting will attract over 1,000 participants, outnumbering last year’s number of delegates.

The conference is organized September 9-10, 2015 at Stockholm Waterfront Congress Centre, Nils Ericssons Plan 4 in Stockholm. More info on


About NLSDays

Founded in 2012 the Nordic Life Science Days has grown rapidly to become the largest Nordic partnering conference for the global life science industry. In 2014, 890 delegates from 28 countries attended the meeting. The 580 companies attending offered 490 licensing opportunities in the partnering system and during the two days 1600 one-on-one meetings were scheduled. Among the investors and big pharma already registered for the meeting in September 2015 are AbbVie, Alexion, Almi Invest, Astellas, AstraZeneca, Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Cadila Pharma, Johnson & Johnson, HealthCap, Industrifonden, Karolinska Development, Merck-MSD, Novartis, Pfizer, Pierre Fabre, P.U.LS. AB, Recipharm, Roche, Seventure Partners, SR-One.

In addition to partnering, NLSDays also offers an exhibition and a seminar program with 10 super session and four topic specific workshops. Speakers include senior representatives from the global life science companies, investors, and academic leaders who will all share their expertise and views for the future.

About SwedenBIO

SwedenBIO who is the founder and organizer of the Nordic Life Science Days is the Swedish life science industry organization. Our nearly 200 members operate across all sub-sectors from pharmaceutical, biotechnology, medical technology to diagnostics. SwedenBIO serves to the benefit the entire life science industry in Sweden and is a member-driven, private, non-profit organization. The main objective is to improve the conditions for the life science industry for the benefit of industry growth and business development.


Oncology Super Session in Stockholm

Oslo Cancer Cluster is hosting a Super Session at the Nordic Life Science Days in Stockholm. International thought leaders will discuss current game changing innovations and their impact on the industry in the years ahead.

Oncology is at the forefront of realizing the promises of precision medicine. Huge and complex datasets are exploited for novel drug development as well as for informed and real-time care decisions. Emerging Cancer immunotherapies represent a paradigm shift for cancer treatment triggering a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.


Moderator: Mr. Richard Godfrey, CEO, BergenBio, Norway

Session Outline:


Min Topic Speaker
5 Introduction by moderator ·        Dr. Richard Godfrey, CEO BerGenBio


10 Topic 1 –global company – perspectives from industry leader – Precision Medicine ·        Dr. Vaios Karanikas, Senior Biomarker and Experimental Medicine Leader, Tumor Immunology, Roche Pharmaceutical Research and Early Development, Innovation Center Zurich
10 Topic 2 – Digital Health company – Big Data / artificial intelligence -> impact on cancer R&D and care ·        Dr. Anthony Bak, Principal Data Scientist, Ayasdi
10 Topic 3 – global company – perspectives from industry leader – Immuno-Oncology ·        Dr. Tim Fisher, Global Lead, Immuno-Oncology / Oncology, Search & Evaluation, Bristol-Myers Squibb
25 Panel Discussion ·        All speakers, joined by Dr. Erik Lund, Director, Worldwide Licensing at MSD (Merck & Co., Inc.)


Target Audience: Start-ups, Biotechs, Pharma, investors, academic innovators, TTOs


Nordic Life Science Innovation Challenge


Are you an aspiring to be a Life Science entrepreneur in Sweden, Norway, Finland or Denmark? Are you passionate about innovation? Do you need more practice on how to create, improve and present a business plan? Do you need professional advise? Then join in on two days to boost your business knowledge

  • Young entrepreneurs develop an already presented business case, provided by researchers from Copenhagen University, DTU, KI Innovation and KTH Innovation.
  • Working in a team to develop a business idea with other young talented professionals from different background and disciplines.
  • Educational training by solving challenges and working with mentors.
  • Commercializing innovative research ideas.
  • Nordic collaboration.

Oslo Cancer Cluster invites all young entrepreneurs to participate in the Nordic Life Science Innovation Challenge, Sept 5-6 in Copenhagen. Oslo Cancer Cluster has the opportunity to provide travel grants of NOK 2500/entrepreneur (up to four Norwegian Entrepreneurs).

You also have the opportunity to subm your research idea/case, you will have the chance to receiving a fresh and updated pitch for a business case based on your idea. Mentors will be present to facilitate the pitch development. You may enter into further collaboration with participants about the development of your idea if there is mutual interest.

The winning team will get free tickets for joining the NLSDays 2015 in Stockholm.

The event is totally free of charge. Oslo Cancer Cluster has the opportunity to provide travel grants of NOK 2500/entrepreneur, up to four Norwegian Entrepreneurs. Regarding the travel grant, please contact Jutta Heix.
The submission deadline is June 15, 2015. More information about the event can be found here

Download all relevant documents here:

NLS Days – time to sign up

Oslo Cancer Cluster is one of the supporting organizations for this years Nordic Life Science Days in Stockholm. Members of the cluster benefit from special rates on participation plus we host an Oncology 2025 Super Session.

In collaboration with LMI, Nansen Neuroscience Network and other healthcare industry actors in Norway, Oslo Cancer Cluster will attend NLSDays to promote Norwegian Healthcare Industry and the cluster members.

Questions regarding the conference may be directed to Jutta Heix, International Advisor or Elisabeth Kirkeng Andersen, Head of Communicaton.

Read the latest newsletter from NLSDays 2015 below or online

The 3rd annual Nordic Life Science Days partnering conference will take place September 9–10 in Stockholm, Sweden, at the Waterfront. NLSDays Super Sessions and Workshops feature top industry leaders and executives speaking on relevant trends to industry decision makers.

Already 50+ Company Presentations confirmed

Presenting at NLSDays is the perfect chance to increase your visibility and attract more partners. Pitch your company’s profile, strategy and objectives to a global audience. Be seen by BD executives, investors, analysts, media and get more activity in partneringONE®. Still a few 6mn and 12mn available slots, don’t miss the opportunity to book your presentation when registering.

Already 50+ Exhibitors confirmed
NLSDays brings hundreds of Life Science Industry leaders from 30+ countries together for 2 days of intensive networking. As an exhibitor, you will reach high-level executives and influential decision makers who come to NLSDays to meet with new players in the industry and initiate partnerships. Still a few 4sqm, 6sqm and 9sqm available stands, don’t miss the opportunity to book yours now.

Oncology 2025 Super Session
Hosted by Oslo Cancer Cluster. Oncology is at the forefront of realizing the promises of precision medicine. Huge and complex datasets are exploited for novel drugs devolpment as well as for informed and real-time care decisions. Emerging cancer immunotherapies represent a paradigm shift for cancer treatment triggening a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.

International Investors Super Session

Hosted by Business Sweden, co-hosted by Industrifonden and HealthCap. Meet the investors actively investing in European Life Sciences companies. What are they looking for? What are the learnings in biotech and medtech investing over the past decade? How are these learnings being applied in current investments decisions? How is the financial climate in Life Sciences today?

Member of a supporting organization?
Since Oslo  Cancer Cluster is a supporting organization, members get a discount. Send an e-mail to Elisabeth Kirkeng Andersen, Head of Communicaton to get the Promotion Code and benefit from discount on all registration fees. Remember that Regular Rate registration period ends on June 30, 2015.

Interested in
sponsoring, exhibiting, presenting ? Contact: Olivier Duchamp,

NLSDays 2015 – Early Bird through March 31

Oslo Cancer Cluster is one of the supporting organizations for this years Nordic Life Science Days in Stockholm, as we were last year. This means that members of the cluster benefit from special rates on participation. Through March 31 you may also get early-bird discount.

In collaboration with other healthcare industry actors in Norway, Oslo Cancer Cluster will have a stand at NLSDays to promote Norwegian Healthcare Industry and the cluster members.

Questions regarding this conference may be directed to Jutta Heix, International advisor or Elisabeth Kirkeng Andersen, Head of Communicaton.

Read the latest newsletter from NLSDays 2015 below.


Why registering now?
Benefit from our Early Bird rates by registering before March 31st, 2015. Book and secure your company presentation slot when registering.

Benefit from an exclusive discount on all NLSDays’ registration rates. Please contact your organization to get your promotion code.


Why attending NLSDays 2015?

NLSDays annually attracts the best from pharma, biotech, medtech and finance the Nordic region has to offer for two days of intense networking. NLSDays’ Super Sessions, topical workshops and vibrant exhibition along with thousands of prescheduled face-to-face meetings make this event the place to be for companies across the Life Science value chain to meet and do business.

Attend NLSDays and take advantage of the opportunity for more partnering meetings in two days than in the rest of the year.

Based on attendance at previous events, NLSDays 2015 will bring together more than 1000 executives from biotechnology, medtech, pharmaceutical and finance companies from the Nordic region and from around the world, who will engage in some 2,000+ face-to-face meetings.


Why presenting at NLSDays 2015?

Presenting at NLSDays gives you a chance to increase your visibility and attract more potential partners. Pitch your company’s profile, pipeline and strategy to a selected audience representing over 30 countries. Be visible by business development executives, investors, media, and increase your activity in the partneringONE platform.

NB: Company presenters receive much more requests and schedule more meetings than non-presenting companies! Presenting companies are also spotlighted in NLSDays marketing material leading up to the event, as well as onsite.
Don’t miss the opportunity to book your presentation slot when registering.

Benefit from Early Bird rate on Company Presentation fees through March 31, 2015.


Why exhibiting at NLSDays?

The 2015 NLSDays Exhibition reflects our 2015 manifesto: “The Life Science Value Chain”.

Regional and country pavilions, from the Nordic Region and Europe, will showcase and host many companies from their regions or countries. Pharma, biotech, medtech and servives providers will join NLSDays exhibition as well.
About partneringONE™, the leading conference networking solution

partneringONE™ powered by EBD Group increase your ROI at the Nordic Life Science Days conference, reduce your overall business development costs and enhance your partnering effectiveness before, during and after the event. partneringONE allows you to:

• Search companies to source potential collaborations and funding opportunities

• Communicate directly with potential investors and/or partners

• Pre-schedule 30-minute face-to-face meetings to be organized onsite.




Why choose Norway as your partner in healthcare R&D?

Norwegian Cancer Society would like to have more innovation from cancer research - for the best of the cancer patients

Norwegian healthcare actors have joined forces and launch the “Norwegian Package” at next weeks Nordic Life Science Days/ECCP. The “Norwegian Package” is five reasons why Norway is a unique place to do research and development within healthcare.

If you would like to learn more – please download a brochure elaborating on the unique features of the Norwegian Healthcare R&D.
Please also come visit our joint stand “Norwegian Healthcare Industry” at the Nordic Life Science Days/ECCP September 7-9 hsoted by Oslo Cancer Cluster and Nansen Neuroscience Network.

Five reasons to collaborate closely with Norwegian actors within Healthcare R&D:

  1. A healthcare system with great opportunities for research
  2. Unique and accessible health registries and biobanks
  3. A great location for clinical trials with a history of delivering on time and quality, a population that is willing to participate in trials and a systematic and transparent regulatory approval process
  4. A strong player in biomedicine with excellent academicresearch environments
  5. A biomedical model that is well adapted for delivering the pharmaceuticals of the future

This is a joint initiative from: Oslo Cancer Cluster, Nansen Neuroscience Network, Innovation Norway, The Research Council of Norway, The Assosiation of the Pharmaceutical Industry in Norway and Link Medical.

Major Oslo Cancer Cluster delegation to Nordic Life Science Days/ECCP2014

The largest Nordic Life Science conference “Nordic Life Science Days” (NLSDays) will take place in Stockholm September 7-9. At present 652 delegates from 456 companies are registered – offering 339 licencing opportunities.

A large delegation from Oslo Cancer Cluster will join this years NLSDays that also features the European Cancer Cluster Partnering, which Oslo Cancer Cluster hosts together with French Cancer Bio-Santé.

17 members present
As of now, 17 Oslo Cancer Cluster member companies will be present at NLSDays/ECCP: APIM Therapeutics, Inven2, Nextera, Ultimovacs, Lifandis, Vaccibody, Norwegian Cancer Society, LINK Medical Research, Lytix Biopharma, Targovax, NTNU Technology Transfer, Oncoimmunity, Bergen Technology Transfer, Birk Venture, Oslo University Hospital, University of Oslo and PCI Biotech.

ECCP Oncology Track
The ECCP Oncology Track features a strong oncology program focusing on three major topics; early stage oncology possibilities, Immuno-Oncology and the coupling of biomarkers, bio banks and big data in cancer treatment. Major international speakers will join and the program covers the whole value chain from research to market.

Norwegian stand promoting Norwegian Healthcare Industry
Kindly sponsored by Innovation Norway, Oslo Cancer Cluster and Nansen Neuroscience Network organizes a joint conference booth promoting cluster members and the Norwegian Life Science sector. Please come and visit us to hear more about the strengths of Norwegian Healthcare Industry. The joint Norwegian Stand will be served by the Management Teams of both clusters.

More information


ECCP Oncology Track Program


The program for the ECCP Oncology Track Sessions at NLS Days/ECCP in Stockolm is now ready. We are proud to present a strong program with international renowned speakers, representing the entire oncology value chain. The program addresses both the most important topics in oncology at the moment, plus the companies that might become the success stories of tomorrow.

Download the program for the ECCP Oncology Track Sessions here.

Immuno-Oncology and Big-Data
The ECCP Oncology Track Sessions of 2014 focus on cancer immunotherapies, the hottest topic within oncology at the moment, early-stage oncology innovations and the utilization of biomarkers, biobanks and big data for developing better cancer treatments. We are proud to present several leading speakers from academics, biotechs, as well as a strong lineup of speakers from international Pharma companies.

The program has been developed in collaboration between several leading European Oncology Milieus such as the Oslo Cancer Cluster, Cancer Bio-Santé, Cancer Campus, BioWin, Medicon Valley Alliance/Invest in Skåne and Health Capital Berlin Brandenburg.

Norwegian stand
Kindly sponsored by Innovation Norway there will be a joint Norwegian stand at ECCP/NLS Days 2014 promoting Oslo Cancer Cluster and Nansen Neuroscience Network. We invite all members to display their marketing material here.

Please contact Elisabeth Kirkeng Andersen for more information on this opportunity.


NLSDAYS-ECCP 2014: Present your oncology innovation

Present your oncology innovation to the global life science industry at the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering (ECCP). Please note that application deadline is May 19th. 12 innovation projects will be selected to present a pitch.

ECCP and the Nordic Life Science Days features a special Oncology Track during the conference that takes place in Stockholm September 7-9 2014. NORTTH – The Nordic Tech Transfer Network/Health and the organizers invite researchers and oncology start-ups to apply to present their pre-commercial cancer projects to pharma industry and potential investors at the conference.

Great opportunity for oncology start-ups
12 pre-commercial cancer research projects will be selected by a review group consisting of oncology experts and technology transfer office representatives. Organizer Olav Steinnes from the largest Norwegian Tech-Transfer Office, Inven2, says: “This is a great opportunity for start-ups to promote their project, to receive feedback from the audience that can direct the research in the right commercial direction, and last but not least to connect to the key people. This event is above all a unique chance for investors to find the licensing opportunities of tomorrow.”

Criteria to be met:

  • Oncology related project (Rx or Dx)
  • Research conducted at a Nordic academic institution
  • Proof of principle demonstrated
  • Ambition to create a start-up or license out within the next 1-2 years

The application should be a maximum 2 page synopsis covering a short description of the technology and IPR situation, development status and planned project milestones over the next 2 years, description of product, intended use and target market.

Submit your application by May 19th, 2014 to Questions regarding the application may be directed to Olav Steinnes on Mobile +47 900 51 219 or E-mail:

Reduced rate
For registration and information about the NLSDays – ECCP 2014 please see
Oslo Cancer Cluster members receive a reduced special offer to participate – read more on this here.

Nordic Life Science Days and ECCP2014 merge


Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering.

Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP 2014 – see more info here.

The 6th European Cancer Cluster Partnering (ECCP) will be integrated in the Nordic Life Science Days in Stockholm September 7. – 9, 2014 as a special Oncology track. Cancer clusters from different European countries have already indicated their interest to team-up for the combined ECCP Oncology stream and the joint event.

“This collaboration is an excellent opportunity to further strengthen the European Cancer Cluster Partnering Platform we have built together with our partner Cancer-Bio-Santé since 2009. The joint event offers enhanced partnering opportunities with more than 800 international delegates and allows us to bring ECCP to Scandinavia once again”, says Oslo Cancer Cluster’s international advisor Jutta Heix.

Olivier Duchamp, Managing Director for Nordic Life Science Days is extremely pleased with the success of last years’ event and says: “This year, our aim is to enhance the Nordic region furthermore and be very focused on recent trends and success stories. We obviously contribute an add-on value to the international partnering arena.”

The 2014 website is launched, and delegates are welcome to register at Download the press release from the web launch here (pdf).

About Nordic Life Science Days (NLSDays)
Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech, but also from finances, research, policy and regulatory authorities. It is the largest Nordic partnering conference for the global Life Science industry, bringing together the best talents in Life Science, offering the excellent networking and partnering opportunities, providing inputs and content on the most recent trends.

About European Cancer Cluster Partnering (ECCP)
Since 2009, ECCP – the European Cancer Cluster Partnering has been established as an annual partnering arena for the international oncology community. ECCP offers a vital networking arena and is the direct result of the close collaboration between two of Europe’s strongest cancer clusters, the French Cancer-Bio Santé Cluster and the Norwegian Oslo Cancer Cluster. The key goal of ECCP is building partnerships to accelerate innovation in cancer treatment.